StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
5533.KL$0.85+0.00%
Fair $0.85+0.0%

5533.KL

OCB Berhad

Consumer Defensive / Packaged FoodsKuala Lumpur

$0.85

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $0.85Fund rank 34/100 · Data gapFallback financials|
SA 78/B
F-Score: 7/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 31% · confianza 25%

FCF escenarios

weak_data · normalized FCF $18.7M · quality 68.3/100

Data gap 34/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 51/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

78/100

B

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 5533.KLLocal privado en este navegador · OCB Berhad
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$88M

P/E

5.7x

↓

EV/EBITDA

2.0x

↓

ROE

8.8%

↑

Gross Margin

21.7%

↓

Debt/Equity

0.22

↓
52-Week Range$1
$1$1

TradingView lightweight chart

5533.KL price, volumen y niveles de valoración

Último $0.855Periodo -72.4%
Fair value: $0.855

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+7.7%

FCF CAGR

—

FCF margin

9.3%

FCF / Net income

1.71x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $318.7M · net income $17.3M · FCF $29.7M

2022-FY → 2025-FY

Gross margin

21.7%+4.2% pts

Operating margin

8.3%+8.1% pts

Net margin

5.4%+6.8% pts

FCF margin

9.3%+9.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$318.7M$318.7M$320.5M$268.4M$254.9M
Net Income$17.3M$17.3M$4.2M$8.5M$-3.6M
EBITDA$33.8M$33.8M$24.6M$24.5M$7.9M
EPS0.170.170.040.08-0.04
Gross Margin21.7%21.7%23.8%21.2%17.5%
Operating Margin8.3%8.3%9.1%5.8%0.2%
Net Margin5.4%5.4%1.3%3.2%-1.4%
Balance Sheet
Debt/Equity0.220.220.330.450.50
Current Ratio2.262.26———
Cash Flow
Free Cash Flow$29.7M$29.7M$14.6M$18.7M$-350000.00
Returns
ROE8.8%8.8%2.3%4.8%-2.1%
Valuation
P/E5.705.7017.888.51—
EV/EBITDA2.022.023.384.2415.55
P/B0.450.450.420.410.46
Growth & Yield
Revenue Growth-0.6%-0.6%19.4%5.3%—
EPS Growth309.7%309.7%-50.4%335.9%—
Dividend Yield4.1%4.1%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-23.3%

fácil

EPS terminal req.

$0.08

Spread vs growth

333.1%

5Y implied EPS CAGR

-11.4%

fácil

EPS terminal req.

$0.09

Spread vs growth

321.2%

10Y implied EPS CAGR

-1.3%

fácil

EPS terminal req.

$0.15

Spread vs growth

311.0%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +33.6%

Total return

+33.6%

Start / end P/E

16.1x → 5.1x

EPS bridge

0.04 → 0.17

Residual

-211.8%

EPS growth+309.7%
Multiple rerating-68.4%
Dividend+4.1%
Residual / FX / buybacks / cross-term-211.8%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.